A Reversal on Sequencing? Proposed Legislation Would Allow Patenting of Naturally Occurring Genes
FDA Law Blog
OCTOBER 24, 2024
In a landmark 2013 decision , a unanimous Supreme Court held that a naturally occurring DNA segment, even when isolated, is a product of nature and therefore does not meet the subject matter eligibility requirement for patentability. By 2010, about 2000 isolated human genes had been patented in the U.S. Supporters of AMP v. Cook-Deegan et al.
Let's personalize your content